Skip to main content

Table 2 Concentrations of methylated arginines in sera of MDS patients and healthy controls

From: Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome

 

MDS

Controls

ap

ADMA [μmol/L]

0.84 ± 0.32

0.56 ± 0.16

0.0022**

SDMA [μmol/L]

0.54 ± 0.18

0.42 ± 0.14

0.0361*

MMA [μmol/L]

0.14 ± 0.05

0.10 ± 0.03

0.033*

Homoarginine [μmol/L]

1.77 ± 1.06

2.32 ± 1.26

0.1777

Citrulline [μmol/L]

46.68 ± 14.96

42.19 ± 12.31

0.3298

MDA [μmol/L]

0.77 ± 0.11

0.52 ± 0.07

<0.001***

Nitrites [μmol/L]

1.71 ± 0.46

2.16 ± 0.38

0.0028**

  1. The data are represented as averages ± SD. ADMA, NG, NG-dimethyl-L-arginine; MMA, NG-monomethyl-L-arginine; SDMA, NG,NG’-dimethyl-L-arginine; MDA, malondialdehyde. aTwo-tailed t-test was used to compare measured concentrations of analytes in MDS patients with healthy donors. Statistical significance coding: * p < 0.05, ** p < 0.01 and *** p < 0.001.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us